OCCHI, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 3.772
EU - Europa 717
AS - Asia 515
OC - Oceania 3
SA - Sud America 3
Totale 5.010
Nazione #
US - Stati Uniti d'America 3.761
IT - Italia 293
CN - Cina 257
DE - Germania 132
SG - Singapore 116
VN - Vietnam 114
FI - Finlandia 71
SE - Svezia 70
GB - Regno Unito 51
FR - Francia 29
UA - Ucraina 29
IN - India 13
IE - Irlanda 9
NL - Olanda 9
CA - Canada 8
GR - Grecia 7
HK - Hong Kong 6
BE - Belgio 5
CZ - Repubblica Ceca 3
JP - Giappone 3
PL - Polonia 3
AZ - Azerbaigian 2
BR - Brasile 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AU - Australia 1
BZ - Belize 1
CL - Cile 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
LI - Liechtenstein 1
RU - Federazione Russa 1
Totale 5.010
Città #
Fairfield 632
Woodbridge 433
Chandler 353
Houston 306
Ashburn 305
Ann Arbor 271
Cambridge 250
Seattle 233
Wilmington 208
Jacksonville 123
Dong Ket 114
Padova 107
Singapore 88
Beijing 83
Princeton 67
San Diego 42
Des Moines 38
Helsinki 35
Medford 32
Nanjing 28
Milan 22
Boardman 19
Falls Church 16
Santa Clara 16
Frankfurt am Main 15
Shenyang 14
London 13
Redwood City 13
Nanchang 10
Nürnberg 10
Dublin 9
New York 9
Zhengzhou 9
Norwalk 8
Jiaxing 7
Catania 6
Florence 6
Jinan 6
Los Angeles 6
Naples 6
Cesano Maderno 5
Changsha 5
Renton 5
Toronto 5
Treviso 5
Borås 4
Casoria 4
Columbus 4
Dallas 4
Dearborn 4
Genoa 4
Hebei 4
Hefei 4
Hong Kong 4
Munich 4
Shanghai 4
Villavesco 4
Waanrode 4
Guangzhou 3
Hangzhou 3
Kharkiv 3
New Bedfont 3
Rome 3
Taiyuan 3
Washington 3
Agrigento 2
Albignasego 2
Barano d'Ischia 2
Bari 2
Brentwood 2
Brno 2
Carmignano Di Brenta 2
Chiswick 2
Council Bluffs 2
Indiana 2
Istanbul 2
Kilburn 2
Kunming 2
Lanzhou 2
Marconia 2
Ogden 2
Paris 2
Phoenix 2
Quarrata 2
Redmond 2
Tacoma 2
Tianjin 2
Turin 2
Turri 2
Vicenza 2
Viganò 2
Vigodarzere 2
Vittorio Veneto 2
Wroclaw 2
Altopascio 1
Americana 1
Amsterdam 1
Atlanta 1
Augusta 1
Azzano Decimo 1
Totale 4.130
Nome #
A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy 182
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 165
Large Genomic Rearrangements of Desmosomal Genes in Italian Arrhythmogenic Cardiomyopathy Patients 162
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 159
Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation 144
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. 137
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 135
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 133
Homozygous desmocollin-2 mutations and arrhythmogenic cardiomyopathy 130
Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. 127
In vivo delivery of naked antisense oligos in aged mdx mice analysis of dystrophin restoration in skeletal and cardiac muscle 126
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 123
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 122
Characterization of C14orf4, a novel intronless human gene containing a polyglutamine repeat, mapped to the ARVD1 critical region 120
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 119
Performance of four models for eye color prediction in an Italian population sample 119
New insight into the Hypercoagulability of Cushing's Syndrome 117
Analysis of gpr101 and aip genes mutations in acromegaly: a multicentric study. 117
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 115
Diagnostic performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma and adrenal insufficiency. 115
Identification and characterization of heart-specific splicing of human Neurexin3 mRNA (NRXN3) 111
Novel mutations in the L1CAM gene support the complexity of L1 syndrome 109
Characterization of a novel human gene containing ANK repeats and ARM domains 106
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 104
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. 103
Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results 102
Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review. 102
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 100
Clinical presentation and management of acromegaly in elderly patients 99
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype 96
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 93
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 92
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging 87
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 86
Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules 83
Silent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: evaluation of a possible molecular link 77
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas 76
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. 73
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 70
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. 67
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. 66
Lesioni ipofisarie nel Carney Complex 62
The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes 61
Carney Complex in clinical practice 55
Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary. 54
Utilità  dell'uso dei test (DDAVP, CRH e 8 MG DEX OVERNIGHT) nell'indicazione chirurgica e nell'outcome della malattia di Cushing 51
Genetica delle forme di iperplasia bilaterale del surrene secernenti cortisolo 47
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 41
La gestione dei carriers nella iperplasia bilaterale surrenalica ARMC5 mutata 32
The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas. 27
KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas 19
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series 19
The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas 17
Paradoxical GH increase after oral glucose load in subjects with and without acromegaly 17
The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a low Risk of Recurrence in Acromegaly 10
The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas 9
A novel somatostatin receptor ligand for human ACTH-and GH-secreting pituitary adenomas 8
null 2
Totale 5.100
Categoria #
all - tutte 18.714
article - articoli 18.332
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 251
Totale 37.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020836 0 0 0 116 91 81 94 110 109 108 89 38
2020/2021903 34 42 53 41 39 42 41 60 112 175 91 173
2021/2022786 22 71 102 58 68 53 39 96 39 18 68 152
2022/2023648 137 93 17 100 73 80 4 40 54 6 32 12
2023/2024430 15 45 52 25 43 42 47 33 14 19 42 53
2024/2025229 19 101 70 39 0 0 0 0 0 0 0 0
Totale 5.100